REDHILL BIOPHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4521 USD | +0.51% |
|
+4.41% | -69.03% |
| 05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
| 04-24 | RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.4610 | 2.880 | 1.990 |
| Spread/Res. | -1.93% | -84.30% | -77.28% |
| Spread/Supp. | +17.43% | +47.50% | +47.50% |
| Support | 0.3850 | 0.3065 | 0.3065 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- RDHL Stock
- Charts RedHill Biopharma Ltd.
